Alliancebernstein L.P. Icad Inc Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.02 - $4.56 $31,408 - $47,423	-10,400 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.92 - $7.48 $7,448 - $14,212	-1,900 Reduced 15.45%	10,400 $46,000
Q4 2021 Feb 14, 2022	SELL	$6.7 - $11.38 $10,050 - $17,070	-1,500 Reduced 10.87%	12,300 $89,000
Q3 2021 Nov 10, 2021	SELL	$10.11 - $17.56 $12,132 - $21,072	-1,200 Reduced 8.0%	13,800 $148,000
Q2 2021 Jul 30, 2021	BUY	$14.9 - $20.82 $29,800 - $41,640	2,000 Added 15.38%	15,000 $260,000
Q2 2020 Aug 13, 2020	BUY	$6.63 - $12.85 $86,190 - $167,050	13,000 New	13,000 $130,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.